February 24th, 2023
•Central nervous system (CNS) tumors are the leading cause of cancer-related death in children, and locoregional immune-based therapies are increasingly being tested for patients in clinical trials. This protocol describes methods for locoregional cannula implantation in mice for the preclinical evaluation of immunotherapeutic infusions targeting CNS tumors.
Tags
Related Videos
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
A Spheroid Killing Assay by CAR T Cells
In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Robot Assisted Distal Pancreatectomy with Celiac Axis Resection (DP-CAR) for Pancreatic Cancer: Surgical Planning and Technique
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Natural Killer (NK) and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved